Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DuoTrav vs Xalacom in Open-Angle Glaucoma
NCT00887029Phase 4Completed
- Sponsor
- Ophthalmic Consultants Centres
- Start
- Jan 2009
- Primary completion
- Nov 2009
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of travoprost in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by Ophthalmic Consultants Centres. Primary endpoint: IOP lowering efficacy at 12 weeks. Started Jan 2009; status: completed.
02
Drugs
travoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00887029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00887029.